معرفی
Aija Linē is a Latvian academic and researcher currently serving as Principal Investigator and Head of the Cancer Molecular Genetics group at the Latvian Biomedical Research and Study Centre (BMC) since 2003. She holds an associate professor position at Riga Stradins University's Department of Biology and Medical Genetics (2004-2005) and has worked as a researcher at the University of Latvia's Faculty of Biology (2005-2008) and BMC (1993-2004). With a PhD in Molecular Biology from 2002, her research focuses on tumor antigens, autoantibody biomarkers, and RNA mechanisms in cancer progression.
- PhD in Biology (University of Latvia, 2002)
Her work spans molecular oncology, immunotherapy, and diagnostic biomarker development, with expertise in aberrant RNA splicing and miRNA dynamics in cancer cells. She investigates zinc enzyme targeting in cancer stem cells and inter-cellular communication during chemotherapy response.
Scientific honors include membership in Academia Europaea (2012), Corresponding Membership at the Latvian Academy of Sciences (2009), and multiple competitive fellowships from UNESCO, Royal Society, and Latvian institutions.
Linē actively contributes to EU regulatory frameworks as European Medicines Agency committee member, evaluates research grants, and serves on editorial boards for Cancer Biomarkers and Central European Journal of Biology. Her laboratory's research directions are detailed at [Aija Linē Lab].
